Lupin

A collection of 3 posts

Sun Pharma, Lupin Issue US Drug Recalls Over Manufacturing Concerns: USFDA Reports

Sun Pharma, Lupin Issue US Drug Recalls Over Manufacturing Concerns: USFDA Reports

Sun Pharma and Lupin respond to USFDA recalls, prompting voluntary product withdrawals. The recalls due to manufacturing issues highlight the significance of quality standards in India's pivotal pharmaceutical exports to the US market.

Zydus and Lupin Join Forces to Market Liver Disease Drug

Zydus and Lupin Join Forces to Market Liver Disease Drug

Zydus Lifesciences and Lupin have forged a strategic partnership to market Saroglitazar Mg, a breakthrough drug for Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steato Hepatitis (NASH) in India. Lupin will have semi-exclusive rights to co-market the drug as LINVAS.

Lupin's Humrahi Manages Diabetes

Lupin's Humrahi Manages Diabetes

Lupin's new program, Humrahi, meaning "Companion," aims to support individuals in managing diabetes effectively. It offers personalized assistance, including diet counseling, medication support, and lifestyle adjustments overseen by healthcare professionals.